MBIO
Price
$1.24
Change
-$0.01 (-0.80%)
Updated
Jun 6 closing price
Capitalization
5.47M
MIRM
Price
$46.38
Change
+$1.73 (+3.87%)
Updated
Jun 6 closing price
Capitalization
2.21B
53 days until earnings call
Interact to see
Advertisement

MBIO vs MIRM

Header iconMBIO vs MIRM Comparison
Open Charts MBIO vs MIRMBanner chart's image
Mustang Bio
Price$1.24
Change-$0.01 (-0.80%)
Volume$40.58K
Capitalization5.47M
Mirum Pharmaceuticals
Price$46.38
Change+$1.73 (+3.87%)
Volume$272.95K
Capitalization2.21B
MBIO vs MIRM Comparison Chart
Loading...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MBIO vs. MIRM commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBIO is a Hold and MIRM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (MBIO: $1.28 vs. MIRM: $43.73)
Brand notoriety: MBIO and MIRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MBIO: 9% vs. MIRM: 50%
Market capitalization -- MBIO: $5.47M vs. MIRM: $2.21B
MBIO [@Biotechnology] is valued at $5.47M. MIRM’s [@Biotechnology] market capitalization is $2.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBIO’s FA Score shows that 0 FA rating(s) are green whileMIRM’s FA Score has 1 green FA rating(s).

  • MBIO’s FA Score: 0 green, 5 red.
  • MIRM’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRM is a better buy in the long-term than MBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBIO’s TA Score shows that 4 TA indicator(s) are bullish while MIRM’s TA Score has 5 bullish TA indicator(s).

  • MBIO’s TA Score: 4 bullish, 4 bearish.
  • MIRM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both MBIO and MIRM are a good buy in the short-term.

Price Growth

MBIO (@Biotechnology) experienced а +7.56% price change this week, while MIRM (@Biotechnology) price change was -1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

MIRM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIRM($2.21B) has a higher market cap than MBIO($5.47M). MIRM YTD gains are higher at: 5.756 vs. MBIO (-85.537). MIRM has more cash in the bank: 280M vs. MBIO (27.5M). MBIO has less debt than MIRM: MBIO (983K) vs MIRM (318M).
MBIOMIRMMBIO / MIRM
Capitalization5.47M2.21B0%
EBITDAN/A-48.97M-
Gain YTD-85.5375.756-1,486%
P/E RatioN/AN/A-
RevenueN/A337M-
Total Cash27.5M280M10%
Total Debt983K318M0%
FUNDAMENTALS RATINGS
MBIO vs MIRM: Fundamental Ratings
MBIO
MIRM
OUTLOOK RATING
1..100
470
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
10021
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6546
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MIRM's Valuation (64) in the null industry is in the same range as MBIO (91) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew similarly to MBIO’s over the last 12 months.

MIRM's Profit vs Risk Rating (21) in the null industry is significantly better than the same rating for MBIO (100) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew significantly faster than MBIO’s over the last 12 months.

MIRM's SMR Rating (97) in the null industry is in the same range as MBIO (100) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew similarly to MBIO’s over the last 12 months.

MIRM's Price Growth Rating (46) in the null industry is in the same range as MBIO (65) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew similarly to MBIO’s over the last 12 months.

MIRM's P/E Growth Rating (100) in the null industry is in the same range as MBIO (100) in the Pharmaceuticals Major industry. This means that MIRM’s stock grew similarly to MBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBIOMIRM
RSI
ODDS (%)
Bullish Trend 12 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
83%
Momentum
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
72%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend about 1 month ago
74%
Declines
ODDS (%)
Bearish Trend 27 days ago
90%
Bearish Trend 12 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
85%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

MBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBIO has been loosely correlated with SLRX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if MBIO jumps, then SLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBIO
1D Price
Change %
MBIO100%
-0.78%
SLRX - MBIO
64%
Loosely correlated
-4.17%
IPHYF - MBIO
42%
Loosely correlated
N/A
SCNI - MBIO
36%
Loosely correlated
-5.60%
MIRM - MBIO
33%
Poorly correlated
-0.32%
GLSI - MBIO
28%
Poorly correlated
-2.61%
More

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with SLRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then SLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
-0.32%
SLRX - MIRM
41%
Loosely correlated
-4.17%
RARE - MIRM
40%
Loosely correlated
-2.08%
CRNX - MIRM
39%
Loosely correlated
+1.39%
FHTX - MIRM
38%
Loosely correlated
+6.17%
KRYS - MIRM
37%
Loosely correlated
-2.44%
More